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Several vitamin K dependent proteins are present in joint tissues,
including matrix gla protein (MGP) which functions as a calciﬁcation
inhibitor. In order for MGP to function it must be g-carboxylated, which
requires vitamin K. Ex vivo studies suggest MGP carboxylation is rele-
vant to osteoarthritis (OA). Assays that measure uncarboxylated MGP
(ucMGP) in plasma have been developed, and elevated plasma ucMGP
reﬂects lower vitamin K status. Whether or not plasma ucMGP is
associated with OA is unclear.
Purpose: To determine the association between plasma ucMGP and
vitamin K1 and knee OA features assessed using MRI in the Health
Aging and Body Composition (Health ABC) study of well-functioning
community-dwelling older adults.
Methods: 437 participants with qualifying knee pain and 144 randomly
chosen controls underwent bilateral knee MRIs (meanSD age ¼ 743
yr; 66% female). Using the WORMS method, the anterior, central, and
posterior of the medial/lateral femoral condyles/tibial plateaus and
medial/lateral subregions of the patella were each semi-quantitatively
scored separately for cartilage damage, bone marrow lesions, sub-
articular cysts, osteophytes, and bone attrition. Meniscal damage was
scored separately in medial and lateral compartments and synovitis
was assessed in the whole knee. Vitamin K status was measured
according to plasma ucMGP and vitamin K1 concentrations. Using the
knee as the unit of analysis, the ORs (95%CIs) for presence of OA char-
acteristics were calculated using logistic regression with generalized
estimating equations (GEEs, to account for between-knee correlation),
according to quartile of each vitamin K status measure. Linear regres-
sionwith GEEs was used to compare the scores for each knee OA feature
across vitamin K status quartiles. Adjustment was made for age, gender,
race, BMI, smoking status, interleukin-6, and education.
Results: Those with lower plasma ucMGP (reﬂective of better vitamin K
status) were signiﬁcantly less likely to have any bone marrow lesions
[OR(95%CI) comparing lowest to highest quartile: 0.59(0.39-0.91), p-
trend¼0.01] and osteophytes [OR(95%CI)¼0.55(0.37-0.84), p-
trend¼0.004]. There was a borderline trend for a lower prevalence of
meniscal damage [OR(95%CI)¼0.68(0.44-1.04), p-trend¼0.049] and
subarticular cysts [OR(95%CI)¼0.75(0.50-1.14), p-trend¼0.07]. In the
linear models, plasma ucMGP was signiﬁcantly positively associated
with total bone marrow lesion score (beta coefﬁcient¼0.085; p¼0.003)
and total subarticular cyst score (beta coefﬁcient¼0.071; p¼0.003).
Plasma ucMGPwas not associatedwith cartilage damage (p0.16), bone
attrition (p0.53), or synovitis (p0.90) and plasma vitamin K1 was not
associated with any MRI knee OA feature (all p0.22).
Conclusion: In this cross-sectional analysis, a marker of lower
vitamin K status, plasma ucMGP, but not vitamin K1 itself was asso-
ciated with some knee OA MRI features, especially those related to
subchondral bone. Longitudinal analyses are needed to determine
whether either plasma ucMGP or vitamin K1, predict changes in knee
OA features.288
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Purpose: Although cigarette smoking has been associated with
a protective effect for osteoarthritis (OA) in several Western studies,
results are conﬂicting and none has examined the effect of smoking
cessation. There is alsonodata fromAsiancountrieswhere theprevalence
of knee OA is increasing. We aimed to examine smoking status, duration,
dosage and cessation in relation to the risk of total knee replacement
(TKR) for severe knee OA among elderly Chinese in Singapore.
Methods: We used data from the Singapore Chinese Health Study,
a population-based prospective cohort of 63,257 Chinese men and
women aged 45 to 74 years at enrolment between 1993 and 1998.
Detailed information on smoking, current diet, medical history and
lifestyle factors were obtained through in-person interviews at enroll-
ment. The cohort has been continuously followed, both actively throughre-interviews and passively through computer linkage to population-
based death and cancer registries. Loss to follow-up has been negligible.
As of 31 December 2011, after a mean follow-up of 14.5 years, 1,950
incident TKR cases for severe knee OA (324 cases inmen and 1,626 cases
in women) were identiﬁed via linkage with nationwide hospital
discharge database. We used the Cox regression models to examine
smoking in relation to risk of TKR with adjustment for age at and year of
study enrollment, level of education, body mass index and physical
activity level.
Results: Compared to never smokers, current smokers had a statisti-
cally signiﬁcant 51% decrease in risk of TKR [hazards ratio (HR)¼0.49;
95% conﬁdence interval (CI)¼0.40-0.60], while former smokers had
a 15% reduction in risk (HR¼0.85; 95% CI¼0.69-1.04). The risk estimates
were similar between both genders. Among current smokers, there was
a very strong dose-dependent association between increasing duration
of smoking and decreasing risk of TKR. Compared to never smokers, the
relative risk decreased from 0.81 (95% CI¼0.47-1.39) in the current
smokers who had smoked less than 20 years to 0.36 (95% CI¼0.26-0.50)
in those who had smoked for 40 or more years (p for trend<0.0001). A
strong negative linear effect of smoking intensity was also detected
with the relative risk decreasing from 0.55 (95% CI¼0.43-0.71) in
current smokers who smoked fewer than 13 cigarettes per day to 0.33
(95% CI¼0.14-0.80) in those who smoked at least 33 cigarettes per day
(p for trend<0.0001), when compared to never smokers. Among former
smokers, there was a stepwise dose-dependent attenuation in the risk
reduction of TKR with duration of cessation. Compared to never
smokers, the relative risk of TKR was 0.68 among those who had quit
less than 1 year, and increased to 0.98 in those who had quit for at least
20 years (p for trend<0.0001).
Conclusions: Our ﬁndings strongly implicate cigarette smoking as
a protective factor for severe osteoarthritis, and this protection is rapidly
lost with smoking cessation. This concurs with experimental data that
nicotine promotes proliferation and collagen synthesis in chondrocytes.
While we certainly do not advocate smoking as a means of preventing
onset or progression of osteoarthritis, understanding the role of nicotine
will elucidate pathogenesis of OA and help in the development of che-
mopreventive agents targeting this putative pathway.289
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Purpose: To study whether participants with symptomatic hand OA
had increased mortality and more cardiovascular events in a pop-
ulation-based cohort, and to explore mechanisms behind a potential
association.
Methods: We included participants from the Framingham Original
and Offspring cohorts between 50 and 75 years, without rheumatoid
arthritis and with available hand radiographs and/or information
about hand pain enabling classiﬁcation of symptomatic hand OA.
Symptomatic hand OA was deﬁned as one or more hand joint(s) with
radiographic OA (Kellgren Lawrence grade 2 or more) and pain in the
same joint(s). Overall mortality included mortality related to
cardiovascular events, cancer and mortality due to unknown/
unspeciﬁed causes. For cardiovascular events, we focused on incident
coronary heart disease (coronary insufﬁciency/myocardial infarc-
tion), congestive heart failure and/or atherothrombotic brain infarc-
tion. The diagnoses were arrived at by a panel of cardiologists/
neurologists using published criteria after review of clinical exami-
nations and hospitalization records. As covariates we included body
mass index (BMI), blood glucose, lipid proﬁle, blood pressure,
medication use (lipid-lowering, antihypertensive, antidiabetics,
nonsteroidal anti-inﬂammatory drugs and aspirin), smoking and
alcohol (for mortality: also previous cardiovascular events and
cancer). The associations to cardiovascular events were studied in
those with no previous events. We examined whether symptomatic
hand OA was associated with all-cause mortality and cardiovascular
events using Cox proportional hazards models adjusting for age, sex,
cohort and BMI (adjusted model one), as well as other covariates at
baseline (adjusted model two).
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(SD) age of 62.7 years and mean (SD) BMI of 27.8 kg/m2 at the time of
hand OA assessment, of whom 339 (24.2%) had symptomatic hand
OA. There was no association between symptomatic hand OA and
overall mortality (table). Although we did not ﬁnd a signiﬁcant
association to cardiovascular events overall, we found a signiﬁcant
association between symptomatic hand OA and coronary heart
disease (table), which was seen in both cohorts when analysed
separately (data not shown). The associations remained after
adjustment for age, sex, BMI and cohorts as well as metabolic risk
factors, smoking, alcohol and medication use (table). There were no
signiﬁcant associations to congestive heart failure and athero-
thrombotic stroke (table).
Conclusions: In the Framingham cohorts, symptomatic hand OA was
not associated with increased overall mortality. However, it was asso-
ciated with an increased risk of coronary heart disease events, whereas
no associations were found to congestive heart failure and athero-
trombotic stroke. These ﬁndings may suggest that there are common
unknown metabolic or systemic risk factors for symptomatic hand OA
and coronary heart disease.Hazard ratio (95% CI) of mortality and cardiovascular events in hand OA (no hand OA as ref)
Crude model Adjusted model 1 (adjusted for age,
sex, BMI and cohort)
Adjusted model two (adjusted for age,
sex, BMI, cohort and other covariates
from baseline)
Overall mortality 1.06 (0.84-1.34) 0.84 (0.66-1.06) 0.86 (0.67-1.11)
Cardiovascular events 1.58 (1.19-2.09) 1.23 (0.91-1.65) 1.33 (0.97-1.82)
- Coronary heart disease 1.88 (1.29-2.76) 1.72 (1.15-2.58) 1.90 (1.23-2.92)
- Congestive heart failure 1.50 (1.04-2.16) 1.11 (0.76-1.61) 1.17 (0.78-1.75)
- Atherotrombotic stroke 1.08 (0.58-2.00) 0.79 (0.42-1.51) 0.82 (0.43-1.59)
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Purpose: Although implant survival and patient-reported outcomes
(PROMs) are considered the most valid measurement of surgery
success, there is a growing interest to identify alternative short-term
surrogates for failure.
We aimed to validate non-steroidal anti-inﬂammatory drugs (NSAIDs)
utilisation in the ﬁrst year following total knee (TKA) and hip (THA)
arthroplasty as a predictor of implant survival.
Methods: Study design and population: A retrospective cohort study
was conducted using data from the Catalan Joint Registry (RACAT)
linked to computerized primary care records and pharmacy invoice
data (SIDIAP Database). We identiﬁed patients aged >¼40 years
undergoing primary TKA/THA for knee/hip osteoarthritis registered in
both RACAT and SIDIAP during the study period (2005-July/2012).
Patients receiving revision surgery in the ﬁrst year post-surgery were
excluded.
- Exposure: NSAID utilisation was measured using pharmacy
invoice data, and quantiﬁed in number of Daily Deﬁned Doses
(DDDs) according to the WHO ATC/DDD index. We further
categorized this into quintiles, and classiﬁed patients in the top
quintile as those having a “poor outcome”.
- Outcome and analysis: Participants were followed up until the
end of study (31/07/2012), date of transfer-out, revision
surgery, or death, whatever came ﬁrst. Fine and Grayregression was used to model implant survival according to
NSAID utilisation taking into account competing risk with
death. Multivariable models were adjusted for gender, age,
socio-economic status, Charlson Comorbidity Index, alcohol
drinking, smoking status, and body mass index.
Results:22,221/23,197 (95.8%) and 10,173/16,703 (60.9%) study partici-
pants were identiﬁed as undergoing TKA and THA for knee and hip
osteoarthritis respectively. TKA and THA participants were followed up
for a median(inter-quartile range) of 3.20 (2.08-4.71) and 2.22 (1.17-
3.72) years. In this time, 724 (3.3%) TKA and 428 (2.6%) THA patients
were revised, 634 (2.9%) and 2,105 (12.6%) died, and 83 (0.4%) and 108
(0.7%) were lost to follow-up before the end of study.
Percentiles 20,40, 60 and 80 of NSAID DDDs used in the ﬁrst year post-
surgery were 35.8, 93.3, 171.7, and 293.4 DDDs amongst TKA patients,
and 6.7, 43.3, 104.5 and 220.0 amongst THA participants. Rates of
revision after the ﬁrst year were positively associated with utilisation of
NSAIDs: adjusted sub-hazard ratio (SHR) 1.22 [95% Conﬁdence Interval
1.14-1.31; p<0.001] per quintile for TKA, 1.29 [1.08-1.54; p¼0.005] for
THA [Figure]. Additionally, 151 (3.9%) patients out of the 3,862 TKA
patients, and 23 (2.1%) out of 1,081 THA participants deﬁned as “badoutcome”were revised compared to 388 (2.11%) and 76 (1.1%) out of the
remaining TKA and THA participants respectively. This corresponded to
adjusted SHR of 1.63 [1.32-2.00], p<0.001 for TKA, and SHR 2.26 [1.33-
3.84], p¼0.002 for THA.
Conclusions: NSAID utilisation in the ﬁrst year following elective TKA/
THA for knee/hip osteoarthritis is directly related to revision risk in
subsequent years. TKA and THA patients within the top quintile of
NSAID usage in that period have 60% and 2.2-fold higher risk of revision
when compared to those requiring lower doses respectively. A deﬁni-
tion of “bad outcome” based on NSAID utilisation in the ﬁrst year post-
surgery is a valid surrogate for implant survival in patients undergoing
primary TKA/THA for osteoarthritis.
